Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDB1 | Q16531 | 1/20 | 0.32 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.32 |
| ▸ | EDNRB | P24530 | 1/20 | 0.31 |
| ▸ | EDNRA | P25101 | 1/20 | 0.31 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.30 |
| ▸ | TDO2 | P48775 | 1/20 | 0.30 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22066152 | 1.00 | DDB1 (0.32) | DDB1CRBNEDNRBEDNRAPTGER4 | |
| SCHEMBL22065768 | 0.98 | DDB1 (0.33) | DDB1CRBNEDNRBEDNRAPTGER4 | |
| SCHEMBL22066108 | 0.98 | DDB1 (0.33) | DDB1CRBNPTGER4KDM4EATM | |
| SCHEMBL22067407 | 0.98 | DDB1 (0.33) | DDB1CRBNPTGER4KDM4EATM | |
| SCHEMBL22065773 | 0.98 | DDB1 (0.33) | DDB1CRBNEDNRBEDNRAPTGER4 | |
| SCHEMBL22066111 | 0.98 | DDB1 (0.33) | DDB1CRBNPTGER4KDM4EATM | |
| SCHEMBL22067391 | 0.97 | DDB1 (0.33) | DDB1CRBNPTGER4KDM4EATM | |
| SCHEMBL22065774 | 0.97 | DDB1 (0.32) | DDB1CRBNPTGER4NPY5RTDO2 | |
| SCHEMBL22065775 | 0.97 | DDB1 (0.32) | DDB1CRBNPTGER4NPY5RTDO2 | |
| SCHEMBL22067090 | 0.96 | DDB1 (0.31) | DDB1CRBNEDNRBEDNRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200185622-A1 | Novel Compound, and Organic Light Emitting Device and Organic Light Emitting Display Device Including the Same | DONGJIN SEMICHEM CO., LTD. (KR) | 2020-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200185622-A1 | Novel Compound, and Organic Light Emitting Device and Organic Light Emitting Display Device Including the Same | ALDH1A2, DDT, TYR | DDB1 387/4885CRBN 1937/4885EDNRB 3812/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.